title: [What's new in dermatological therapy?].
abstract: This non-exhaustive review focuses on publications that have been the subject of randomized controlled trials. It will also include results from research that may lead to new therapeutic perspectives. The selected articles were published between October 2013 and September 2014. The vast majority of them were dedicated to the treatment of psoriasis (anti-TNF, ustekinumab, antibodies against IL-17 or its receptors, anti-IL-23, anti-CD6 and ponesimod). Selected papers will also address the following diseases: atopic dermatitis, urticaria, acne, bullous diseases, alopecia areata, skin infections, acne rosacea and leg ulcers.
authors.affiliation: Service de dermatologie, CHRU Carémeau, avenue du Professeur-Robert-Debré, 30029 Nîmes, France. Electronic address: laurent.meunier@chu-nimes.fr.
authors.forename: L
authors.initials: L
authors.lastname: Meunier
mesh_terms: D001688:Biological Products / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D003880:Dermatology / Q000639:trends*; D006801:Humans; D015337:Multicenter Studies as Topic; D012871:Skin Diseases / Q000188:drug therapy / Q000628:therapy*; D035703:Therapies, Investigational
chemical_list: D001688:Biological Products; D003879:Dermatologic Agents
keywords: Acne; Acné; Alopecia areata; Atopic dermatitis; Biotherapy; Biothérapie; Dermatite atopique; Pelade; Psoriasis; Urticaire; Urticaria